α-Neoendorphin (1-8) is a 8-amino acid peptide derived from the N-terminal of α-Neoendorphin. α-Neoendorphin is an endogenous opioid peptide.
α-Neoendorphin 1-8 is a synthetic peptide fragment derived from the endogenous opioid peptide α-neoendorphin, consisting of the N-terminal eight amino acids. As a member of the dynorphin/neoendorphin family, it plays a significant role in neuropeptide research due to its involvement in modulating pain perception and synaptic signaling in the central nervous system. Its defined sequence and bioactive properties make it an important tool for studies focused on opioid receptor interactions, neurophysiological processes, and the broader landscape of peptide-mediated cellular communication.
Receptor binding studies: Researchers frequently utilize α-Neoendorphin 1-8 in receptor binding assays to investigate the specificity and affinity of opioid peptides for different receptor subtypes, particularly the κ- and δ-opioid receptors. By employing this peptide fragment, scientists can delineate the structural features responsible for receptor selectivity and signal transduction, enabling a deeper understanding of the molecular determinants of opioid receptor activation and modulation.
Neuropeptide signaling research: The peptide serves as a valuable probe for dissecting the mechanisms of neuropeptide signaling within neuronal circuits. Experimental models employing α-Neoendorphin 1-8 facilitate the exploration of peptide release, synaptic transmission, and downstream intracellular pathways. Its use allows for the characterization of how truncated opioid peptides influence neuronal excitability, neurotransmitter release, and the integration of sensory information at the molecular and cellular levels.
Peptide structure-activity relationship (SAR) analysis: α-Neoendorphin 1-8 is instrumental in structure-activity relationship studies designed to map the functional domains of opioid peptides. By comparing the biological activity of this truncated sequence to that of full-length neoendorphins and related analogs, researchers can identify critical residues involved in receptor interaction, agonist or antagonist behavior, and peptide stability. Such insights support the rational design of novel peptide analogs with tailored pharmacological profiles for basic research purposes.
Peptide synthesis and analytical method development: The defined sequence of α-Neoendorphin 1-8 makes it a useful standard in the development and validation of peptide synthesis protocols and analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry. Its use as a reference compound enables accurate quantification, purity assessment, and method optimization, which are essential for ensuring reproducibility and reliability in peptide research workflows.
Cellular signaling pathway elucidation: In cell-based assays, α-Neoendorphin 1-8 is applied to investigate the activation of downstream signaling cascades initiated by opioid receptor engagement. Its effects on second messenger systems, such as cyclic AMP and calcium flux, provide valuable data on the coupling of opioid receptors to intracellular effectors. Such studies contribute to a comprehensive understanding of how endogenous peptides regulate physiological and biochemical responses in neural and non-neural tissues.
2. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
4. Cationic cell-penetrating peptides are potent furin inhibitors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More